The Jockey Club has called on leading industry organizations to come together to conduct a study that would examine the timing of administration of furosemide (known as Salix or Lasix), the medication used to prevent or lessen the effects of exercise-induced pulmonary hemorrhage (EIPH).

At the June 17 meeting of the Kentucky Equine Drug Research Council (KEDRC), member A. Gary Lavin, DVM, suggested a study examining the efficacy of Salix at varied administration times. Currently Salix is the only race-day medication allowed in U.S. racing and it typically is administered four hours before competition.

The KEDRC advises the Kentucky Horse Racing Commission on medication policies and awards money for funding of medication studies.

Jockey Club executive director Matt Iuliano attended the meeting to offer support of the study and called on industry leaders to come together to fund and shape it. A veterinarian, Lavin represents breeders on the KEDRC and is a Jockey Club member

Create a free account with TheHorse.com to view this content.

TheHorse.com is home to thousands of free articles about horse health care. In order to access some of our exclusive free content, you must be signed into TheHorse.com.

Start your free account today!

Already have an account?
and continue reading.